Bridging the Gap: How Innovation-Driven Partnerships Fuel the Pace of Cell Therapy Manufacturing Development

Successfully automating a cell therapy manufacturing program requires flexibility, process understanding, and collaboration to push boundaries and unlock new possibilities. This panel explores considerations for transitioning to automated systems, developing a roadmap to implementation and how collaborative partnerships can assist in navigating this path, streamlining cell therapy process development and manufacturing.

In this session, the following is discussed:

• Driving factors for transitioning to automated systems at different stages of the development journey. What do manufacturing expectations look like and how do they change from clinical development to commercial scale?
• The transformative potential of configurable, modular, and customizable solutions that cater to the unique requirements of cell therapy production.
• The need for flexible and adaptable platforms that can scale and the importance of thinking about this early in the process.
• Benefits of partnerships and their positive impact on accelerating the pace of cell therapy manufacturing development by rethinking how to overcome obstacles and design a robust process.

Watch this engaging discussion highlighting innovation-driven partnerships’ crucial role in bridging the gap between current practices and future advancements in cell therapy manufacturing.

This Workshop was produced in partnership with Invetech.